Student Research Committee, School of Medicine, Bam University of Medical Sciences, Bam 44340847, Iran.
Department of Pharmacy, University of Pisa, Via Bonanno 6, 56126 Pisa, Italy.
Biomolecules. 2018 Dec 23;9(1):6. doi: 10.3390/biom9010006.
Epibatidine is a natural alkaloid that acts at nicotinic acetylcholine receptors (nAChRs). The present review aims to carefully discuss the affinity of epibatidine and its synthetic derivatives, analogues to nAChRs for α4β2 subtype, pharmacokinetic parameters, and its role in health. Published literature shows a low affinity and lack of binding of epibatidine and its synthetic analogues to plasma proteins, indicating their availability for metabolism. Because of its high toxicity, the therapeutic use of epibatidine is hampered. However, new synthetic analogs endowed from this molecule have been developed, with a better therapeutic window and improved selectivity. All these aspects are also discussed here. On the other hand, many reports are devoted to structure⁻activity relationships to obtain optically active epibatidine and its analogues, and to access its pharmacological effects. Although pharmacological results are obtained from experimental studies and only a few clinical trials, new perspectives are open for the discovery of new drug therapies.
依匹巴林是一种作用于烟碱型乙酰胆碱受体(nAChRs)的天然生物碱。本综述旨在详细讨论依匹巴林及其合成衍生物、对α4β2 亚型 nAChRs 的类似物的亲和力、药代动力学参数及其在健康中的作用。已发表的文献表明,依匹巴林及其合成类似物与血浆蛋白的亲和力低且无结合,表明它们可用于代谢。由于其高毒性,依匹巴林的治疗用途受到阻碍。然而,已经开发出从该分子衍生而来的新型合成类似物,具有更好的治疗窗口和改善的选择性。所有这些方面也在这里进行了讨论。另一方面,许多报告致力于构效关系的研究,以获得光学活性的依匹巴林及其类似物,并研究其药理作用。尽管药理学结果来自于实验研究,只有少数临床试验,但为发现新的药物治疗方法开辟了新的前景。